產(chǎn)品基本信息
產(chǎn)品編號：I163750
產(chǎn)品名稱：Icatibant Acetate
產(chǎn)品CAS：138614-30-9
規(guī)格含量：5mg
產(chǎn)品價格：面議
聯(lián)系我們:
產(chǎn)品詳細(xì)介紹
標(biāo)準(zhǔn)品編號:
I163750
名稱:
Icatibant Acetate
別名:
D-Arginyl-L-arginyl-L-prolyl-(4R)-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-(3R)-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-(2S,3aS,7aS)-octahydro-1H-indole-2-carbonyl-L-arginine Acetate Salt; D-Arginyl-L-arginyl-L-prolyl-trans-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-D-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-L-(2α,3aβ,7aβ)-octahydro-1H-indole-2-carbonyl-L-arginine Acetate Salt; Firazyr; HOE 140
CAS號:
138614-30-9
參考CAS號:
Deleted CAS: 148699-92-7
分子式:
C??H??N??O??S x(C ?H?O?)
外觀:
白色固體
熔點(diǎn):
213-218°C
分子量:
1304.52
儲存:
-20°C Freezer, Under inert atmosphere
溶解度:
DMSO (Slightly), Water (Slightly)
種類:
Standards; Amino Acids/Peptides; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Icatibant Acetate is a bradykinin B2 receptor antagonist that has been recently approved for treatment of acute attacks of hereditary angioedema (HAE).
參考文獻(xiàn)
Greve, J., et al.: Int. J. Dermatol., 50, 1294 (2011); Cole, S.W., et al.: Ann. Pharmacother., 47, 49 (2013)
?您的位置：
